VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-00726
Package ID: USCOURTS-cofc-1_18-vv-00726
Petitioner: Judith A. Bridges
Filed: 2018-05-23
Decided: 2018-06-20
Vaccine: Pneumococcal 23
Vaccination date: 2017-09-05
Condition: allergic reaction consisting of a red and hot arm, shoulder pain, headaches, and ongoing allergic reactions to various foods
Outcome: dismissed
Award amount USD: 

AI-assisted case summary:
On May 23, 2018, Judith A. Bridges, proceeding pro se, filed a claim in the National Vaccine Injury Compensation Program. She alleged that on September 5, 2017, she received the Pneumococcal 23 (Pneumovax 23) vaccine in her right arm and subsequently experienced an allergic reaction. Her alleged symptoms included a red and hot arm, shoulder pain, headaches, and ongoing allergic reactions to various foods. Ms. Bridges also received an influenza vaccine on the same day in her left arm but did not attribute her injuries to it. During an initial status conference on June 19, 2018, Special Master Thomas L. Gowen explained to Ms. Bridges that claims under the Vaccine Program are only permissible for vaccines listed on the Vaccine Injury Table. He informed her that the Pneumovax 23 vaccine is not on the Table and therefore not covered by the program. Ms. Bridges stated that she believed she was reporting the reaction for statistical purposes. As the vaccine was not covered by the program, Special Master Gowen determined that the petition failed to state a claim upon which relief could be granted. Respondent, represented by Alexis B. Babcock of the United States Department of Justice, did not object to this dismissal. Judgment was entered accordingly on June 20, 2018, dismissing the petition.

Theory of causation field:
Petitioner Judith A. Bridges filed a claim alleging an allergic reaction including a red and hot arm, shoulder pain, headaches, and ongoing food allergies following vaccination with Pneumovax 23 on September 5, 2017. The claim was filed on May 23, 2018. The Special Master, Thomas L. Gowen, determined that the Pneumovax 23 vaccine is not listed on the Vaccine Injury Table, and therefore, the claim failed to state a valid claim under the National Vaccine Injury Compensation Program. The petition was dismissed on June 20, 2018, as the vaccine was not covered. Petitioner was represented by herself (pro se), and respondent was represented by Alexis B. Babcock. The public decision does not describe the specific mechanism of injury, expert testimony, or award details, as the case was dismissed on threshold grounds.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-00726-0
Date issued/filed: 2018-07-23
Pages: 2
Docket text: PUBLIC DECISION (Originally filed: 6/20/2018) regarding 9 DECISION of Special Master. Signed by Special Master Thomas L. Gowen. (fm) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-00726-UNJ Document 10 Filed 07/23/18 Page 1 of 2
REISSUED FOR PUBLICATION
ORJGINAL
JUL 23 2018
OSM
U.S. COURT OF FEDERAL CLAIMS
3ln tbe Wntteb of jfeberal
~tate% ~ourt ~lafmg
OFFICE OF SPECIAL MASTERS
F1LED
Filed: June 20, 2018
* * * * * * * * * * * * * * * * * * * * * * * * * UNPUBLISHED JUN 2 0 20\8
JUDITH A. BRIDGES, * u
S COURT OF
* No. 18-726V FEDERAL CLAIMS
Petitioner, *
v. * Special Master Gowen
*
SECRETARY OF HEAL TH * Dismissal; Pneumovax 23;
AND HUMAN SERVICES, * Vaccine Injury Table; Allergies.
*
Respondent. *
* * * * * * * * * * * * * * * * * * * * * * * * *
Judith A. Bridges, petitioner, prose.
Alexis B. Babcock, United States Department of Justice, Washington, DC, for respondent.
DECISION ON ENTITLEMENT1
On May 23, 2018, Judith A. Bridges ("petitioner"), actingpro se, filed a claim within the
National Vaccine Injury Compensation Program ("Vaccine Program").2 Petitioner alleged that
she received the Pneumococcal 23 ("Pneumovax 23") vaccination in her right arm on September
5, 2017, and immediately suffered an allergic reaction consisting of a red and hot arm, shoulder
pain, headaches, and ongoing allergic reactions to various foods. Petition (ECF No. 1) .
Petitioner also noted that she received the influenza vaccination in her left arm on the same day,
but did not attribute it to her alleged injury. Id.
On June 19, 2018, the undersigned held an initial status conference in the case. Petitioner
appeared prose. Ms. Alexis Babcock appeared on behalf of respondent. I explained that under
the Vaccine Act, a petitioner is only able to pursue a claim for a vaccination that is set forth in
the Vaccine Injury Table. § 1 l(c)(l)(A). I then explained to petitioner that the Pneumovax 23
1 Pursuant to the E-Govermnent Act of2002, see 44 U.S.C. § 350 I note (2012), because this decision contains a
reasoned explanation for the action in this case, I intend to post it on the website of the United States Court of
Federal Claims. The court's website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. Before the decision
is posted on the coui1's website, each pm1y has 14 days to file a motion requesting redaction "of any information
furnished by that party: (1) that is a trade secret or cormnercial or financial in substance and is privileged or
confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly
unwarranted invasion of privacy." Vaccine Rule 18(b). "An objecting pat1y must provide the couit with a
proposed redacted version ofthe decision." Id. If neither party files a motion for redaction within 14 days, the
decision will be posted on the court's website without any changes. &
2 The National Vaccine Injury Compensation Program is set forth in Patt 2 of the National Childhood Vaccine
Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-10 to 34 (2012)
(hereinafter "Vaccine Act" or "the Act"). Hereinafter, individual section references will be to 42 U.S.C. § 300aa of
the Act.

Case 1:18-vv-00726-UNJ Document 10 Filed 07/23/18 Page 2 of 2
vaccine is not listed on the Vaccine Injury Table and thus is not covered by the Vaccine
Program. See 42 CFR § 100.3. Petitioner thanked me for explaining this fact to her and
clarified that she thought she was supposed to report the allergic reaction for statistical pmposes.
I informed petitioner that the only choice we had was to dismiss the claim since the Pneumovax
23 vaccine is not covered. Respondent had no objections to this course of action.
The Pneumovax 23 vaccine is not set forth in the Vaccine Injury Table. Thus, the
petition is dismissed for failing to state a claim upon which relief can be gra te . The
Clerk of the Court shall enter judgment accordingly.
IT IS SO ORDERED.
Special Master
2